Insider Transactions in Q1 2024 at Novo Cure LTD (NVCR)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2024
|
Wilhelmus Cm Groenhuysen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,217
-0.48%
|
$19,472
$16.01 P/Share
|
|
Mar 04
2024
|
Frank X Leonard EVP, Pres., Novocure Oncology |
SELL
Open market or private sale
|
Direct |
840
-0.52%
|
$13,440
$16.01 P/Share
|
|
Mar 01
2024
|
Wilhelmus Cm Groenhuysen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,107
-0.83%
|
$33,712
$16.03 P/Share
|
|
Mar 01
2024
|
Frank X Leonard EVP, Pres., Novocure Oncology |
SELL
Open market or private sale
|
Direct |
1,679
-1.03%
|
$26,864
$16.03 P/Share
|
|
Feb 28
2024
|
Frank X Leonard EVP, Pres., Novocure Oncology |
SELL
Open market or private sale
|
Direct |
2,078
-1.26%
|
$33,248
$16.14 P/Share
|
|
Feb 28
2024
|
Wilhelmus Cm Groenhuysen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,303
-0.9%
|
$36,848
$16.14 P/Share
|
|
Feb 27
2024
|
Ashley Cordova Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
102,249
+31.74%
|
$1,635,984
$16.3 P/Share
|
|
Feb 27
2024
|
Nicolas Leupin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,124
+50.0%
|
$817,984
$16.3 P/Share
|
|
Feb 27
2024
|
Michal Nath Puri Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
71,574
+39.6%
|
$1,145,184
$16.3 P/Share
|
|
Feb 27
2024
|
Frank X Leonard EVP, Pres., Novocure Oncology |
BUY
Grant, award, or other acquisition
|
Direct |
102,249
+38.3%
|
$1,635,984
$16.3 P/Share
|
|
Feb 27
2024
|
Moshe Giladi Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,124
+42.29%
|
$817,984
$16.3 P/Share
|
|
Feb 27
2024
|
Uri Weinberg Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
81,799
+32.34%
|
$1,308,784
$16.3 P/Share
|
|
Feb 27
2024
|
Wilhelmus Cm Groenhuysen Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,034
+15.48%
|
$752,544
$16.3 P/Share
|
|
Feb 27
2024
|
Barak Ben Arye General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
81,799
+41.12%
|
$1,308,784
$16.3 P/Share
|